PHAGEBANK SUSCEPTIBILITY TEST Trademark

Trademark Overview

On Thursday, October 14, 2021, a trademark application was filed for PHAGEBANK SUSCEPTIBILITY TEST with the United States Patent and Trademark Office. The USPTO has given the PHAGEBANK SUSCEPTIBILITY TEST trademark a serial number of 97074042. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, February 7, 2023. This trademark is owned by Adaptive Phage Therapeutics, Inc.. The PHAGEBANK SUSCEPTIBILITY TEST trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

diagnostic kits comprised of medical diagnostic reagents for testing for bacteria sensitivity

diagnostic reagents for clinical and medical laboratory use; diagnostic kits comprised of reagents for testing for bacteria sensitivity

providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of bacteria infections, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services; medical analysis services relating to the diagnosis and treatment of person; microbiological laboratory testing of bacteria for diagnostic and medical purposes, and technical consultation thereto; medical testing and diagnostic services for diagnostic or treatment purposes, in particular performing tests using diagnostic assays

providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of bacterial infections, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; laboratory research in the field of genomic sequencing; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of bacteria and viruses; laboratory research in the field of infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; microbiological laboratory testing of bacteria for research purposes, and technical consultation thereto; scientific and medical research, in particular design and development of diagnostic assays
phagebank susceptibility test

General Information

Serial Number97074042
Word MarkPHAGEBANK SUSCEPTIBILITY TEST
Filing DateThursday, October 14, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, February 7, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesdiagnostic kits comprised of medical diagnostic reagents for testing for bacteria sensitivity
Pseudo MarkPHAGE BANK SUSCEPTIBILITY TEST
Goods and Servicesdiagnostic reagents for clinical and medical laboratory use; diagnostic kits comprised of reagents for testing for bacteria sensitivity
Goods and Servicesproviding medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of bacteria infections, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services; medical analysis services relating to the diagnosis and treatment of person; microbiological laboratory testing of bacteria for diagnostic and medical purposes, and technical consultation thereto; medical testing and diagnostic services for diagnostic or treatment purposes, in particular performing tests using diagnostic assays
Goods and Servicesproviding medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of bacterial infections, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; laboratory research in the field of genomic sequencing; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of bacteria and viruses; laboratory research in the field of infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; microbiological laboratory testing of bacteria for research purposes, and technical consultation thereto; scientific and medical research, in particular design and development of diagnostic assays

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, November 3, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 3, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 3, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 3, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAdaptive Phage Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Tuesday, February 7, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, February 7, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, February 7, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, July 22, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 22, 2022NON-FINAL ACTION E-MAILED
Friday, July 22, 2022NON-FINAL ACTION WRITTEN
Wednesday, July 20, 2022ASSIGNED TO EXAMINER
Wednesday, November 3, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 18, 2021NEW APPLICATION ENTERED

Related Keywords

test susceptibility phagebank diagnostic medical testing research services purposes laboratory bacteria field prognostic